Cargando…
Comorbidities Associated With Residual Cardiovascular Risk in Patients With Chronic Coronary Syndrome Receiving Statin Therapy ― Subanalysis of the REAL-CAD Trial ―
Background: Even with high-dose statin therapy, residual cardiovascular event risks remain in patients with chronic coronary syndrome (CCS). Thus, future treatment targets need to be elucidated. This study determined the factors associated with residual cardiovascular risk in patients with CCS treat...
Autores principales: | Wakabayashi, Kohei, Suzuki, Hiroshi, Fukumoto, Yoshihiro, Obara, Hitoshi, Kakuma, Tatsuyuki, Sakuma, Ichiro, Kimura, Takeshi, Iimuro, Satoshi, Daida, Hiroyuki, Shimokawa, Hiroaki, Nagai, Ryozo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437477/ https://www.ncbi.nlm.nih.gov/pubmed/36120482 http://dx.doi.org/10.1253/circrep.CR-22-0070 |
Ejemplares similares
-
High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study
por: Omote, Kazunori, et al.
Publicado: (2022) -
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022) -
Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022) -
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial
por: Taguchi, Isao, et al.
Publicado: (2018) -
Risk factor structure of heart failure in patients with cancer after treatment with anticancer agents’ assessment by big data from a Japanese electronic health record
por: Nohara, Shoichiro, et al.
Publicado: (2023)